Article Details
Retrieved on: 2025-01-08 21:49:25
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Nirsevimab, a monoclonal antibody, is approved to prevent RSV lower respiratory tract disease (LRTD) in neonates and infants entering, or born during ...
Article found on: www.contemporarypediatrics.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here